Aptus Capital Advisors LLC raised its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 29.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 49,639 shares of the semiconductor company's stock after acquiring an additional 11,269 shares during the period. Aptus Capital Advisors LLC's holdings in Lam Research were worth $3,609,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently added to or reduced their stakes in LRCX. Smallwood Wealth Investment Management LLC purchased a new stake in Lam Research during the first quarter valued at about $26,000. West Paces Advisors Inc. purchased a new stake in shares of Lam Research in the fourth quarter worth about $27,000. Mpwm Advisory Solutions LLC purchased a new stake in shares of Lam Research in the fourth quarter worth about $27,000. Park Square Financial Group LLC purchased a new stake in shares of Lam Research in the fourth quarter worth about $31,000. Finally, Putney Financial Group LLC purchased a new stake in shares of Lam Research in the fourth quarter worth about $36,000. Hedge funds and other institutional investors own 84.61% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have recently weighed in on the company. Summit Insights downgraded Lam Research from a "buy" rating to a "hold" rating in a research report on Thursday, July 31st. Stifel Nicolaus upped their target price on Lam Research from $92.00 to $110.00 and gave the stock a "buy" rating in a research report on Tuesday, July 29th. UBS Group boosted their price target on Lam Research from $95.00 to $120.00 and gave the stock a "buy" rating in a research note on Monday, July 21st. Raymond James Financial boosted their price target on Lam Research from $90.00 to $110.00 and gave the stock an "outperform" rating in a research note on Thursday, July 31st. Finally, Morgan Stanley boosted their price target on Lam Research from $87.00 to $94.00 and gave the stock an "equal weight" rating in a research note on Thursday, July 31st. Twenty investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $107.30.
Get Our Latest Stock Report on LRCX
Lam Research Stock Up 1.7%
NASDAQ LRCX traded up $1.67 on Friday, hitting $100.08. 9,687,561 shares of the stock traded hands, compared to its average volume of 12,639,810. The stock has a 50-day moving average of $98.41 and a 200 day moving average of $84.59. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $108.02. The company has a market capitalization of $126.66 billion, a P/E ratio of 24.06, a price-to-earnings-growth ratio of 1.28 and a beta of 1.65. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The semiconductor company reported $1.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.12. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The firm had revenue of $5.17 billion for the quarter, compared to analysts' expectations of $4.99 billion. During the same quarter in the prior year, the firm posted $1.03 earnings per share. Lam Research's revenue for the quarter was up 33.6% compared to the same quarter last year. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. As a group, analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.
Lam Research Profile
(
Free Report)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.
Featured Stories

Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.